Day OneTuesday, 29 April 2025 - GMT (Greenwich Mean Time, GMTZ)

M&A Masterclass

Part 1: Deep Dive into the Current M&A Landscape

• Overview of the Pharma M&A Landscape
  • Current trends and statistics in pharma M&A
  • Impact of recent M&A deals on the industry
• Importance of M&A for Biotechs
  • How M&A can provide biotechs with resources, market access, and expertise
  • Strategies for biotechs to position themselves as attractive targets or acquirers
• Key Considerations for Successful Transactions
  • Essential elements of due diligence, valuation methods, and metrics
  • Importance of cultural fit and post-acquisition integration

Part 2: How to Turn a 10-Person Biotech into a $1.1Bn Acquisition in 7 Years

Presented by Renee Aguiar-Lucander, CEO, Calliditas

• Motivation Behind the Acquisition
• Process Overview
• Outcome and Lessons Learned
• Future Considerations

IPO Masterclass

Part 1: Understanding the IPO Landscape

• Overview of the IPO Market
  • Current trends and statistics in biotech IPOs
  • Key factors driving IPO activity in the sector
• Advantages and Challenges of Going Public
  • Access to capital, visibility, and credibility benefits
  • Regulatory, operational, and financial challenges associated with IPOs
• Pre-IPO Preparation
  • Key steps to ensure readiness, including financial audits and governance

Building a compelling investment story for investors

Part 2: Case Study – From Startup to IPO

• Strategic Decision to Pursue an IPO
• Navigating the IPO Process
• Key Outcomes and Lessons Learned
• Long-Term Strategies Post-IPO